CluePoints provides risk-based quality management software solutions, focusing on using advanced statistics and machine learning to improve clinical development outcomes. The company self-describes as an innovator in the RBQM space.

CluePoints

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Content Delivery Network

Google Maps

Senior Vice President Product

Adrien Lebrun

Finance and Administration

Amit Patel

Co-Founder & Chief Executive Officer

Francois Torche

Chief Operations Officer

Holly Gratkowski

Chief Scientific Officer

Steve Young

Vice President, Partnerships

Andrea Mcsweeney

Senior Vice President, Customer Success

Dan Beaudry

VP Product Management & Customer Success

Erik Doffagne

VP Business Operations

James Faust

Vice President, Customer Success

Jamie O'Neill

Thomas M. Tarnowski

François Torche

Chief Design Officer

Andrew Cooper

Chief Executive Officer

Richard Davies

Vice President, Solution Expert

Marc Buyse

Founder and Chief Scientific Officer

Richard Young

Northeastern US Acquired Companies With Fewer Than 1000 Employees (Top 10K)

Software Companies With Fewer Than 1000 Employees (Top 10K)

United States Acquired Companies With Less Than $500M in Revenue (Top 10K)

Acquired Greater Philadelphia Area Companies

CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.

Summit Partners

Private Equity Round - CluePoints

S.R.I.W.

Series A - CluePoints

King Of Prussia

Pennsylvania

United States

North America

CluePoints Appoints Richard Young as Chief Strategy Officer

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

EQT acquiring clinical trial AI software biz CluePoints

CluePoints Receives Majority Investment from EQT

EQT agrees majority stake in clinical trial software company CluePoints

Hg details plans to grow AuditBoard; EQT acquires majority stake in CluePoints

EQT to Buy Majority Stake in Clinical Trial Analytics Provider CluePoints

Utilizes the CluePoints patented SMART engine to analyze clinical and operational data within trials, detecting atypical data patterns that could indicate issues such as sloppiness, tampering, systemic errors, or fraud.

A set of metrics pre-defined by the Sponsor or CRO to illuminate risks during clinical trials, comparing data across protocols, countries, or sites to identify potential issues.

A set of trial-level parameters defined at the planning stage to monitor key study metrics and document any deviations, helping to ensure compliance with regulatory guidelines.

Identifies subjects who simultaneously enroll in multiple trials or across multiple sites for a single trial, addressing data integrity issues and patient safety risks.

Provides a consolidated view of data from multiple sources into a single visual timeline for each patient, aiding in medical review and highlighting specific areas of interest.

Offers comprehensive analytics and elegant visualizations to help users drill down into risks and critical data points within their studies, supporting hypothesis testing and critical thinking.

United Kingdom

Europe

India

Asia

Belgium

Bangladesh

HTML5

Lightbox

F5 NGINX

Modernizr

Office 365

Gravity Forms

Wordpress

Cloudflare CDN

Google Compute Engine

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 14, 2024 3:35 PM	f612df57
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 14, 2024 3:35 PM	26c17e8d
crunchbase trigger	general	Dec 4, 2024 8:54 AM	7eb527d3
crunchbase profile	general	Dec 4, 2024 12:43 PM	f7d41640
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 1:38 PM	eec56c84
peers	general	Oct 14, 2024 3:35 PM	d7c2b9b2
news basic	general	Oct 14, 2024 3:35 PM	d044b8ae
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CLUEPOINTS

CluePoints